Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05347082Not ApplicableCompleted
Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment
Hyperparathyroidism, PrimaryHyperparathyroidism, SecondaryHypovitaminosis D+2 more
PrincipalinvestigatorStart date: 2021-04-29

Research Network

Collaboration Network

6 collaborators·7 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Peri-postmenopause and bone metabolism clinic. Regional Hospital October 1st ISSSTE.

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Juan M Ocampo Godínez, M.D., Ph.D.

Tissue Bioengineering Laboratory, National Autonomous University of Mexico [UNAM]

Similar
2 trials

Shared therapeutic areas:

Hypovitaminosis DOsteoporosis, PostmenopausalHyperparathyroidism, Primary+2 more

Worked with same sponsors:

Hospital Regional 1o de OctubreNational Polytechnic Institute, Mexico+1 more
Collaborated on 1 trial
Similarity Score54%

Patricia Loranca-Moreno, M.D., M.Sc.

Peri-postmenopause and bone metabolism clinic. Regional Hospital October 1st ISSSTE.

Similar
3 trials

Shared therapeutic areas:

Hypovitaminosis DOsteoporosis, PostmenopausalHyperparathyroidism, Primary+2 more

Worked with same sponsors:

Hospital Regional 1o de OctubreNational Polytechnic Institute, Mexico+1 more
Collaborated on 1 trial
Similarity Score54%

Huma Riaz, Phd*

Riphah International University

Related
19 trials

Shared therapeutic areas:

PostmenopauseOsteoporosis, Postmenopausal
Similarity Score12%

David J Whellan, MD MHS

Thomas Jefferson University

Related
5 trials

Shared therapeutic areas:

Hypovitaminosis DHyperparathyroidism, Secondary
Similarity Score12%

Janet E Hall, M.D.

Massachusetts General Hospital

Related
7 trials

Shared therapeutic areas:

Postmenopause
Similarity Score6%

Nancy D. Perrier, MD

M.D. Anderson Cancer Center

Related
11 trials

Shared therapeutic areas:

Hyperparathyroidism, Primary
Similarity Score6%

Stergios A Polyzos, MD, PhD

School of Medicine, Aristotle University of Thessaloniki

Related
2 trials

Shared therapeutic areas:

Osteoporosis, Postmenopausal
Similarity Score6%

Andreas Nikolis, MD, PhD

Erevna Innovations Inc.

Related
6 trials

Shared therapeutic areas:

Postmenopause
Similarity Score6%

Dimitrios G Goulis, MD, PhD

School of Medicine, Aristotle University of Thessaloniki

Related
2 trials

Shared therapeutic areas:

Osteoporosis, Postmenopausal
Similarity Score6%

Anne McTiernan, MD, PhD

Fred Hutchinson Cancer Center

Related
4 trials

Shared therapeutic areas:

Hypovitaminosis D
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05347082Not ApplicablePrincipalInvestigator

Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment

Hyperparathyroidism, PrimaryHyperparathyroidism, SecondaryHypovitaminosis D+2 more
Completed

All 1 trials loaded